Roche and partner Klinrisk have picked up a CE-mark in the EU for an AI-based tool that can be used to predict renal function decline in patients with chronic kidney disease (CKD). The algorithm will ...
This political trifecta is "currently the most likely scenario as things stand," a traditional bookmaker has told Newsweek.
Roche has picked up a CE Mark approval in the EU for an artificial intelligence algorithm that can help doctors decide whether patients presenting with acute chest pain are having a heart attack. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results